Ultragenyx Pharmaceutical Inc. (53) | Intellectual Property (4)

Browse by Subcategory

License Agreements (4)

Recent Contracts

Second Amendment to Option and License Agreement, dated December 17, 2021, by and between REGENXBIO, Inc. and Ultragenyx Pharmaceutical Inc (Filed With SEC on February 15, 2022)
Amendment to the License Agreement, dated as of March 22, 2013, between Ultragenyx Pharmaceutical Inc. and Baylor Research Institute (Filed With SEC on February 12, 2021)
License Agreement, dated as of September 20, 2012, between Ultragenyx Pharmaceutical Inc. and Baylor Research Institute (Filed With SEC on February 12, 2021)
First Amendment to Option and License Agreement entered into March 18, 2019 between REGENXBIO Inc. and Ultragenyx Pharmaceutical Inc. (as assignee of Dimension Therapeutics, Inc.) (Filed With SEC on May 7, 2019)